Mayne Pharma $125 million syndicated financing

25/6/2015

Financing, Refinancing

Value:

$ 125 million

Status:

Completed

Date:

25/6/2015

Overview:

Mayne Pharma agreed a new syndicated dual currency loan with two Australian banks.
The new $125 million facility, which matures in June 2020, will in part be used to refinance the company's outstanding $45 million debt.

Ben Naylor - Regional editor

Jurisdiction:

Australia

Deal types:

Financing
Refinancing

Practice area:

Banking

Governing law:

Australia

Industry sector:

Pharmaceuticals and life sciences

Firm:

MinterEllison

Party: Mayne Pharma Group (Borrower)

Related deals